ConvaTec Group PLC (CTEC)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

274.20p

Buy

274.60p

arrow-up1.40p (+0.51%)

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.
Prices updated at 19 May 2025, 17:09 BST
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-up0.14%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
1,765m1,832m1,827m1,894m2,038m2,073m2,142m2,289m
926m974m956m1,019m1,123m1,104m1,201m1,284m
248m268m97m211m204m221m265m332m
14.0414.615.3011.149.9910.6712.3814.49
158m222m10m113m118m63m130m191m
402m455m292m417m398m340m456m540m
Sales, General and administrative637m656m699m725m825m791m825m840m
Interest expenses58m64m64m44m36m49m73m74m
Provision for income taxes6m-20m9m62m34m19m37m56m
Operating expenses679m706m859m808m920m883m935m952m
Income before taxes164m201m19m175m151m82m167m246m
Net income available to common shareholders158m222m10m113m118m63m130m191m
0.080.110.0049720.0570.0590.0310.0640.093
Net interest income-62m-65m-74m-48m-43m-52m-75m-78m
Advertising and promotion--------
Net investment income, net-24m-3m-5m-26m4m-26m4m-18m
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)0.080.110.0049590.0560.0580.0310.0630.093
Free cash flow per share0.04650.10860.12160.10930.10350.07060.04390.0998
Book value/share0.52040.62410.61420.55830.62940.64270.62410.6451
Debt equity ratio1.1449670.9779250.9707880.8631710.7497050.7951170.76310.698443

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets875m903m968m1,179m1,111m889m870m793m
Current liabilities323m331m397m513m569m533m536m512m
Total capital3,269m3,175m3,006m3,041m2,895m2,822m2,920m2,812m
Total debt1,823m1,644m1,575m1,549m1,435m1,300m1,312m1,202m
Total equity1,524m1,617m1,561m1,671m1,695m1,610m1,693m1,689m
Total non current liabilities--------
Loans1,745m1,558m1,445m1,370m1,200m1,212m1,227m1,123m
Total assets3,801m3,660m3,610m3,767m3,674m3,592m3,714m3,515m
Total liabilities--------
Cash and cash equivalents289m316m386m565m463m144m98m65m
Common stock1,952m1,966m1,984m2,004m2,015m2,044m2,046m2,044m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period264m289m316m386m565m463m144m98m
Cash dividends paid-26m-75m-80m-63m-86m-88m-111m-130m
222m280m340m313m212m138m238m274m
Investments (gains) losses-183m-81m-73m-56m-206m-348m-286m-161m
289m316m386m565m463m144m98m65m
Net income--------
307m352m402m400m306m282m367m396m
-85m-72m-61m-86m-94m-144m-129m-122m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.